Authors
Dianhong Zhao, Liguang Zheng
Published in
Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology. Volume 44. Issue 4. Pages 462-471. Aug 01, 2026.
Abstract
Acute toothache is a common dental emergency. In 2023 and 2024, the American Dental Association successively issued evidence‑based clinical practice guidelines for the pharmacologic management of acute dental pain in children, adolescents, adults, and older adults, establishing a new system that prioritizes nonsteroidal anti‑inflammatory drugs, strictly limits opioids, and implements age‑specific precise management. This article systematically interprets the evidence‑based foundation and age‑specific medication regimens of the guidelines. By integrating relevant Chinese diagnostic and treatment standards, expert consensuses, and the National Essential Medicines List, it explores localized implementation pathways from the perspectives of drug accessibility, prescribing habits, policy alignment, and primary healthcare resource allocation. It proposes age‑stratified analgesic regimens suitable for China and provides actionable recommendations for evidence‑based training, multidisciplinary collaboration, patient education, and pharmaceutical supervision. This article aims to provide Chinese dentists with a decision‑making reference for the pharmacological treatment of acute toothache that incorporates the latest international evidence and local realities, thereby promoting standardized and scientific acute oral pain management in China.
PMID:
42576753
Bibliographic data and abstract were imported from PubMed on 11 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0